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In his dissertation thesis, Lukáš Górecki deals mainly with the synthesis of several series of 
acetylcholine esterase (AChE) modulators and subsequently with in vitro evaluation of their 
properties like inhibition/reactivation of various choline esterases (ChE), their effects on cell 
viability or potential to cross biological membranes (blood-brain barrier). The dissertation thesis 
is written in standard way. In the introduction section, the author summarized the current 
knowledge in the fields important for the objectives of his work. Main part of the thesis consist of 
the design and synthesis of tacrine inhibitors of ChE, then insect´s AChE-targeting inhibitors, and 
finally three series of the reactivators of organophosphate- and organophosphonate-inhibited 
AChE. Some of the prepared compounds showed very promising properties and thus will be used 
as the lead compounds in further in vivo studies. 
The dissertation thesis has 22 % rate of similarities according to Turnitin system. Although this 
number looks high, the majority of similarities are in the experimental section (including the 
sequences of NMR signals etc.) and there are very few similarities in the written text. Therefore, 
from this point of view, I can say that this work is composed of the original texts and results, 
which did not appear previously. 
The thesis is written in English language. As I am not a native speaker, I cannot objectively 
evaluate the grammar and style. Nonetheless, I found several mistakes and some formulations are 
not easily understandable (e.g. abstract it believed, in Czech wrong form “nervosvalových 
spojích”, page 25 - these leads,  page 33 have proved effective, page 32 - release of a leaving 
group release, page 39 – in addition the parent…, page 56 - In the next step was important for the 
preparation of alkylating intermediates. etc.). 
In my opinion this Ph.D. thesis suffered from 3 major issues. 
1. I found that candidate is not the first author (even not second or third) of original 
experimental-type article in the journal with IF. Lukáš Gorecki is the first author of two 
official reviews (Arch. Toxicol 2016; Expert Opin. Ther. Pat. 2017) and one review 
(Arch. Toxicol, 2018) that is presented by the publisher as original article. But I did not 
find any experimental section there. So my first important question is: Did the candidate 
perform some experimental work for this article? 
2. I am not satisfied with the characterization of many of intermediates and products (no one 
from any relevant journal would be). It is not enough to present just H NMR. In some 
cases, it can be tolerated, mainly when the comparison with known data are presented. 
However, it is not the case in this work. 
Moreover, there are several compounds, marked as pure and/or with high yields, but the 
evidence for structure/purity is missing. This is not possible in the scientific text. 
The compound 170 is characterized only with H NMR and the yield is 98%, with no 
purification. Many authors presented significantly lower yields with another isomer (6-
nitro) to be present in the final mixture. Similar problem can be found with compound 
174. 
Compounds 211 and 226 had the yields >99%. It is nonsense, only possible explanation is 
that these compounds contain some impurities. Again, any evidence for these results are 
missing (only H NMR spectra are shown). 
3. It was really difficult and tiring to read and understand the discussion part, because author 
did not use the numbers for the intermediates and some of final compounds, which he 
commented. So it was time-consuming to look back for the structures and try to find the 
appropriate ones. E.g. see paragraph on page 90. It is very confusing. Even some 
mysterious codes like PMS20, PY18 appeared, with no structure or some relevant 
comment. 
Other comments/questions: 
1. Abbreviations - chemical formulas are not abbrev. – e.g. PPh3, MeCN, EtOH 
2. Page 19. Author wrote that esteratic site is 17,7Å from Ser200. But figure 2 and scheme 1 
show that Ser200 is the part of esteratic site. So what is esteratic site and where is Ser200? 
3. Page 21. “Organophosphates bind competitively?” Is it true? Can you comment it? 
4. Page 42. What is the meaning of the sentence: “The maleimide moiety was confirmed by 
the in vitro results.“ 
5. It would be beneficial for the reader to find the ranges of yields in Schemes 9, 10, 11, 15 
etc. and yields in table 2, 4 etc.  
6. Scheme 15 – conditions h) are not included in the caption 
7. Scheme 16 – compound 158 is an ester 
8. Table 5 and 7 – some standard, like parent compound tacrine, should be included to allow 
the comparison of the results of new derivative with it 
9. Table 7 – footnote a is not mentioned in the table; same as with c, d in table 8; c in table 9 
10. Please, can you comment the pKa values summarized in Table 18. E.g. for compound 
229.  
11. According to exp. section, compounds 229-236 were prepared according to method E. But 
method E is completely different and cannot proceed to these compounds. 
12. Isolation and purification of compounds 234, 235 and 236 as mentioned in the discussion 
(page 95) is completely different that those described in experimental section. 
13. In the section 4.2 if the conclusion, it would be very welcomed by the reader if some SAR 
picture/scheme is provided. Again, just the text is not enough for easy understanding. 
14. In the figure 28, the compounds are marked with KXXX, so the reader does not know 
what compounds are they. 
15. Page 98, 3rd paragraph – “Unfortunately, all compounds, including the standards, were 
able to cross MDCK cell line.“ This sentence is also quite confusing. Please comment it. 
16. Page 97. What is ATCh? Please, can you explain the meaning of the sentence in which 
ATCh is used? 
 
Additional questions: 
1. Page 34. Does the anion in the reactivator play any role in the reactivation potency/ 
ADME properties? 
2. Regarding the designed maleimide insecticides. What about the other cystein residues in 
the human body. In my opinion, the maleimide would act as non-selective Michael 
acceptor and will react with various nucleophiles. Did you also check the effects to 
mammalian cells? 
3. The antioxidant activities are shown in table 6. But I did not find any experimental details 
and I am not sure, what is the meaning of the „% at 10 mM“. 
4. Page 89, 4.1.2. I found in exp. Section, that only AlCl3 and ZnCl2 were used. Did you try 
another Lewis acid, as you indicated in the text? 
5. Can you show me the possible interaction of His447 with maleimide part of the inhibitor, 
which can irreversibly inhibit the enzyme (page 97)? What about the nucleophilic residue 
of serine in the CAS and its possible reaction with maleimide. 
 
Reviewer can conclude that candidate fulfilled the majority of the objectives and prepared a huge 
series of compounds with interesting properties regarding the modulation of ChE. I am sure that 
they will become a crucial part of several research articles. In addition, the overall publication 
activity of the candidate is very good, despite the fact, that in my opinion he is not the first author 
of any truly experimental work.  
 
Finally, this Ph.D. thesis can be considered as sufficient for the defense and thus I 
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